NAFLD patients exhibited significantly higher expression levels of vitamin A storage‐related genes (LRAT and DGAT1), retinaldehyde dehydrogenases 1 and 3 (RALDH1 and 3), and degradation genes (Cyp26A).52 This evidence concerns the gene ALDH1A1 and metabolic dysfunction-associated steatotic liver disease.